<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
84581-002-01
</NDCCode>
<PackageDescription>
30 mL in 1 BOTTLE (84581-002-01)
</PackageDescription>
<NDC11Code>
84581-0002-01
</NDC11Code>
<ProductNDC>
84581-002
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Airface Nicotinamide Facial Correcting Serum
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Airface Nicotinamide Facial Correcting Serum
</NonProprietaryName>
<DosageFormName>
LIQUID
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20240726
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH DRUG
</MarketingCategoryName>
<ApplicationNumber>
M016
</ApplicationNumber>
<LabelerName>
GUANGZHOU SHANGPIN BIOTECHNOLOGY CO.,LTD
</LabelerName>
<SubstanceName>
ALPHA-ARBUTIN; NIACINAMIDE; TRANEXAMIC ACID
</SubstanceName>
<StrengthNumber>
1; 5; 2
</StrengthNumber>
<StrengthUnit>
g/100mL; g/100mL; g/100mL
</StrengthUnit>
<Pharm_Classes>
Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2025-07-30
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20251231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20240726
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>